Improvements in depression and anxiety are associated with greater intensity of mystical experiences and higher ratings of the spiritual significance and personal meaning.
"You have to start somewhere. These issues are important. When you introduce legislation, people start taking it more seriously."
Herein, we report the solid state structure of 4-acetoxy-N,N-dimethyltryptamine fumarate.
This structure reveals some reasons for the long-lasting effects of LSD and gives insight into the role of receptor signaling.
The combined action of magic mushroom compounds produces the overall psychedelic experience.
Bruce Tobin is asking Health Canada to approve psilocybin to treat anxiety and depression in end-of-life patients.
Enter the fascinating world of the chemistry and biology of these psychedelics.
FDA approval for psilocybin-assisted therapy for depression appears to be on the horizon.
Don't be confused by the similar spelling and chemical structure. These are two very distinct compounds.
The importance of baeocystin in the overall effects of magic mushrooms is not understood and often overlooked. Here are some ideas to help fill the research gap.